Dec 16 (Reuters) - U.S. Health Secretary Robert F. Kennedy Jr. on Tuesday added two rare genetic disorders, Duchenne Muscular Dystrophy and Metachromatic Leukodystrophy, to the federal newborn screening list to enable early treatment, the Department of Health and Human Services said.
The decision updates the Recommended Uniform Screening Panel (RUSP), which guides state-level newborn screening programs, following a scientific review and public comment process.
Early detection of Duchenne Muscular Dystrophy (DMD) and Metachromatic Leukodystrophy (MLD) will allow children to receive FDA-approved therapies at the most effective time, helping slow disease progression and preserve quality of life, the HHS said.
DMD, a rare genetic disorder, causes muscle degeneration, while MLD affects the brain and nervous system, which leads to loss of motor and cognitive function and early death.
Most children with DMD or MLD are diagnosed at age four or five, when significant muscle loss or neurological decline has already occurred, the HHS said.
The agency said that screening at birth could reduce years-long diagnostic delays, repeated specialist visits, and the financial and emotional strain often associated with rare diseases.
(Reporting by Siddhi Mahatole in Bengaluru; Editing by Shinjini Ganguli)
Historic underwater structure discovered by divers off French coast- The Reduced Portage Horse: An Inheritance Reconsidered for Present day Experience
- Supercharge Your Remote Work Arrangement with These Game-Changing Instruments
- EU calls on Western Balkans to step up reforms for membership
- Watch Blue Origin's huge New Glenn rocket ace its epic landing on a ship at sea (video)
- Eating ultra-processed foods could raise precancerous polyp risk for women under 50, according to research
- Bismuth’s haredi draft bill won’t change enlistment, IDI expert tells 'Post'
- The Developing Nearby Food Development and Its Advantages
- Russia Creates New Military Branch Dedicated To Drone Warfare
